{
    "clinical_study": {
        "@rank": "117608", 
        "arm_group": [
            {
                "arm_group_label": "L-thyroxine", 
                "arm_group_type": "Active Comparator", 
                "description": "Oral administration, starting dose 25 or 50 micrograms once daily."
            }, 
            {
                "arm_group_label": "blank", 
                "arm_group_type": "No Intervention", 
                "description": "no intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Subclinical hypothyroidism (SCH) is a common condition affecting 3-10% of the general\n      population, especially in women older than 50 years old. It is controversial whether SCH can\n      lead to increased risks of cardiovascular (CV) disease and whether treatment with\n      L-thyroxine reverses these risks. The present study was designed to evaluate the effect of\n      L-thyroxine treatment in SCH on lipid profile, atherosclerosis, endothelial function, serum\n      inflammatory factors and adipocytokines."
        }, 
        "brief_title": "Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypothyroidism", 
            "Thyroid Diseases", 
            "Endocrine System Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Endocrine System Diseases", 
                "Hypothyroidism", 
                "Thyroid Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female aged of 18 to 60 years old;\n\n          -  Diagnosis was subclinical hypothyroidism(elevated serum thyroid-stimulating hormone\n             levels with normal serum free T4 levels measured at least two times with a\n             three-month interval);\n\n          -  untreated.\n\n        Exclusion Criteria:\n\n          -  Pregnancy or lactation women;\n\n          -  Presence of pituitary/hypothalamic disorders, diabetes mellitus or other endocrinal\n             and metabolic disorders;\n\n          -  Presence of psychological or physical disabilities,acute infection, cerebrovascular\n             or cardiovascular disease, chronic respiratory disease and other illnesses known to\n             alter lipid metabolism;\n\n          -  Taking lipid-lowering agents and other drugs that known to influence thyroid\n             function, blood pressure, heart function or bile acids;\n\n          -  Obviously poor compliance."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831869", 
            "org_study_id": "2012GSF11824"
        }, 
        "intervention": {
            "arm_group_label": "L-thyroxine", 
            "intervention_name": "L-thyroxine", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Subclinical hypothyroidism", 
            "L-thyroxine", 
            "Lipid", 
            "endothelial function", 
            "inflammatory factor", 
            "adipocytokine"
        ], 
        "lastchanged_date": "December 1, 2013", 
        "location": {
            "contact": {
                "email": "shaoshanshan11@126.com", 
                "last_name": "Shanshan Shao", 
                "phone": "86-531-68776094"
            }, 
            "facility": {
                "address": {
                    "city": "Jinan", 
                    "country": "China", 
                    "state": "Shandong", 
                    "zip": "250021"
                }, 
                "name": "Shandong Provincial Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Beneficial Effect of L-Thyroxine Long -Term Replacement on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism: A Prospective Study", 
        "overall_contact": {
            "email": "gaoling1@medmail.com.cn", 
            "last_name": "Ling Gao", 
            "phone": "+86 53168776910"
        }, 
        "overall_official": {
            "affiliation": "Shandong Provincial Hospital", 
            "last_name": "Jiajun Zhao", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "change in lipid profile", 
                "safety_issue": "No", 
                "time_frame": "measured at baseline; 6 month; 12 months and 24 months."
            }, 
            {
                "measure": "change in thickness of blood vessel wall", 
                "safety_issue": "No", 
                "time_frame": "measured at baseline; 6 months; 12 months and 24 months."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831869"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shandong Provincial Hospital", 
            "investigator_full_name": "Ling Gao", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "change in endothelial function", 
                "safety_issue": "No", 
                "time_frame": "measured at baseline; 6 months; 12 months and 24 months."
            }, 
            {
                "measure": "change of adipocytokines", 
                "safety_issue": "No", 
                "time_frame": "measured at baseline; 6 months; 12 months and 24 months."
            }, 
            {
                "measure": "Change of Oxidative Stress and Chronic Inflammatory Factors Related with Atherosclerosis", 
                "safety_issue": "No", 
                "time_frame": "measured at baseline; 6 months; 12 months and 24 months."
            }
        ], 
        "source": "Shandong Provincial Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shandong Provincial Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}